Daybreak Brief — Archive

May 17 - May 23, 2026
Intelligence Briefing

Curated intelligence on finance, geopolitics, security and technology — Daybreak Brief archive.

All archives →

This week's briefing

01

May 18, 2026

SES AI Faces Investor Lawsuit Over Misleading Claims

Finance

Hold onto your hats, folks! SES AI Corporation is in hot water as the Schall Law Firm is rallying investors for a class action lawsuit. They're accusing SES of making some dodgy claims that left investors with empty pockets between January 2025 and March 2026. Seems like SES might have been a bit too optimistic—or just downright misleading—about their business deals. What does it mean for you? If you were banking on SES and ended up with a loss, this is your chance to jump into the lawsuit and try to recover some of those hard-earned dollars. Just don't miss the June 26 deadline to join the party.

Sourced from verified tier-one publications · Our sources

02

May 18, 2026

SES AI Faces Lawsuit Over Misleading Financial Claims

Finance

SES AI Corporation is in hot water as DJS Law Group has filed a class action lawsuit against them for allegedly making false statements about their financial performance. The suit claims SES traded access to its platform for services from vendors, misleading investors during the period from January 29, 2025, to March 4, 2026. If you're an investor feeling the burn, you might want to check in with DJS Law Group about joining the case. What does it mean for you? If you bought SES shares during the specified time and are seeing red in your portfolio, it's worth looking into this lawsuit. You could potentially reclaim some of those losses if the case goes in favor of the plaintiffs.

Sourced from verified tier-one publications · Our sources

03

May 18, 2026

Heyedrate Clinical: Revolutionizing Dry Eye Relief

Safety

EyePromise has launched Heyedrate Clinical, a new artificial tear product designed to offer quick relief for dry eyes. This innovative product uses advanced technology to mimic natural tears, promising improved eye comfort and hydration for those struggling with dry eyes. What does it mean for you? If you've been battling dry eyes from too much screen time or other factors, Heyedrate Clinical could be a game-changer, potentially reducing your need for frequent eye drops and improving overall eye comfort.

Sourced from verified tier-one publications · Our sources

04

May 18, 2026

Revolutionary Eyedrops Offer Long-Lasting Relief

Safety

EyePromise just launched a new artificial tear product called Heyedrate Clinical, which is designed to tackle dry eyes with cutting-edge technology. This new product uses a fancy version of hyaluronic acid to keep those peepers moist and comfy for longer, reducing the need for constant reapplication. And good news for contact lens wearers, you can use these drops without interrupting your lens-wearing routine. What does it mean for you? If your eyes often feel like the Sahara, this new product might offer longer-lasting relief, meaning less time spent fiddling with eyedrops and more time enjoying life without the irritation.

Sourced from verified tier-one publications · Our sources

05

May 23, 2026

Commvault Faces Investor Lawsuit After Share Plunge

Resources

Commvault Systems is in hot water after a lawsuit hit the fan, claiming the company misled investors about its growth prospects. Things took a nosedive when their Q3 2026 financial results flopped, causing a 31% drop in share value. The lawsuit alleges that Commvault was not upfront about how different types of sales were affecting their growth, especially with lower-priced SaaS deals. What does it mean for you? If you're a Commvault investor, this might sting a bit with potential losses. Keep an eye on updates, and if you have any inside info, there's a chance for you to help out and maybe even get a reward.

Sourced from verified tier-one publications · Our sources